Skip to main content

Diversity in Lupus Clinical Trials: Why Is It Important?

In this commentary, Saira Sheikh, MD, from the University of North Carolina at Chapel Hill, discusses the lack of diversity in lupus clinical trials and how it can negatively impact patients’ rheumatologic health.
Article Type
Resource Center
Image URL
Back to Top